Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasoconstrictor drugs in the treatment of hepatorenal syndrome
2006-005014-13Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Jun 2007
- Modality
- Peptides, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of terlipressin, octreotide, midodrine and albumin (human) in hepatorenal syndrome (HRS) (2 arms), sponsored by Azienda Ospedaliero-Universitaria di Padova. Primary endpoint: Total recovery of renal function. Started Jun 2007; status: active.
02
Drugs
terlipressinoctreotidemidodrinealbumin (human)
03
Conditions
hepatorenal syndrome (HRS)
Beyond the preview
Go deeper on 2006-005014-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005014-13.